Loading
NASDAQHealthcareMedical - Devices
Latest quote
$3.11
−$0.02 · -0.64%
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Latest quote
$3.11
−$0.02 · -0.64%
After-hours
$3.1018
−$0.0082 · -0.26%
Oct 9, 4:04 PM ET
Regular session · ET · Market data may be delayed.
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Day range
Current $3.11
52-week range
Current $3.11
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
45
Fair Value
Sentiment
51
Mixed
Risk
66
High Risk
Momentum
19
Strong Down
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. The company’s technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders. Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.
Day range
Current $3.11
52-week range
Current $3.11
Operating income
Net income
| Metric (USD) | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Cost of goods sold | 12K USD | — | — | — | — |
| Gross profit | −12K USD | — | — | — | — |
| Research and development | 7.14M USD | 4.73M USD | 2.23M USD | 745K USD | 4.07K USD |
| Selling, general, and administrative | 9.89M USD | 6.86M USD | 5.25M USD | 1.25M USD | 13.59M USD |
| Operating expenses | 17.02M USD | 11.59M USD | 12.03M USD | 1.99M USD | 13.59M USD |
| Interest income | 319K USD | 354K USD | 127K USD | — | — |
| Interest expense | — | 176K USD | 79K USD | — | 218.09K USD |
| Depreciation and amortization | 12K USD | 183K USD | 81K USD | — | — |
| Operating income | −17.03M USD | −11.59M USD | −12.03M USD | −1.99M USD | −13.59M USD |
| Net income | −16.72M USD | −11.41M USD | −15.43M USD | −1.99M USD | −13.33M USD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
AI-generated and delayed market data for informational and educational purposes only. Not investment advice.
